731P Post-progression Survival Outcomes in Patients (pts) with Primary Advanced or Recurrent Endometrial Cancer (pa/rec) in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial Who Received Follow-Up Immunotherapy
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要